Fundacion Centro Nacional De Investigaciones Oncologicas Carlos III

Part of Instituto De Salud Carlos III

UEI
Y3GZCML28HM3
CAGE
516DB
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • Foundation
  • Foreign Government
Entity structure
Country - Foreign Government
Corporate family
SAM.gov registration date
Website
cnio.es
Founded
1998
Employees
251-1K
Estimated annual revenue
$50M-$100M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
  4. Health Care Services
SIC code
80 Health Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Clinical qualification of DNA repair defects as biomarkers in metastatic prostate cancer using integrated genomics… W81XWH1810770 Defense Health Agency $625,318
Role of exosomes and endoglin in neurofibromatosis progression W81XWH1610131 Medical Command (Army) $463,862
The unfolded protein response in melanoma progression and chemoresistance R01CA125017 National Institutes of Health $1,015,087
Tailoring new drugs in pancreatic cancer R01CA129963 National Institutes of Health $936,396
Individualized treatment of pancreatic cancer R01CA116554 National Institutes of Health $751,459

Grant subawards

Prime recipient Prime award Amount Awarded
Weill Medical College Of Cornell University The Real Lab will first analyze tissue samples for evidence of muscle invasion, as well as querying expression of luminal and basal tumor cell markers. They… R21CA266660 $138,763
European Molecular Biology Laboratory The CNIO will continue to work with data from proteomics pipelines to validate gene models to discover further coding genes and transcripts novel to GENCODE. We… U24HG007234 $97,948
Weill Medical College Of Cornell University The Real Lab will first analyze tissue samples for evidence of muscle invasion, as well as querying expression of luminal and basal tumor cell markers. They… R21CA266660 $138,763

Similar vendors

Vendor Location Primary NAICS
Instituto De Salud Carlos III UEI RZNMV91DKMP8 Madrid, MD —
Universitat Pompeu Fabra CCT UEI NXF3F6V81C18 Barcelona, CT 611310 Colleges, Universities, and Professional Schools
Centro Nacional De Investigaciones Cardiovasculares Carlos III (F.s.p.) UEI KBFFGZHX41J7 Madrid, MD —
Fundacio Institut D Investigacio Biomedica De Bellvitge Idibell UEI T24CKEMW3Q93 L'Hospitalet de Llobregat, CT 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Fundacio De Recerca Clinic Barcelona-Institut D’investigacions Biomediques August Pi I Sunyer UEI L8DUH7HTDX46 Barcelona, CT 813212 Voluntary Health Organizations

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Fundacion Centro Nacional De Investigaciones Oncologicas Carlos III is a foreign-owned foundation registered in SAM.gov since 2007, with its registration set to expire on February 6, 2026. Located in Madrid, Spain, the organization is structured as a foreign government entity and has been recognized for its participation in federal grant sub-awards. While specific details about the organization's primary mission are not provided in the available data, the entity appears to be focused on oncological and molecular research, working closely with international academic and research institutions.

The organization has recently engaged in sophisticated scientific research through federal grant sub-awards, primarily collaborating with prestigious institutions like Weill Medical College of Cornell University and the European Molecular Biology Laboratory. Their recent work encompasses advanced genomic and proteomic research, including analyzing tissue samples for muscle invasion, developing spatial transcriptomic data analysis techniques, and working on gene model validation. Specifically, they have been involved in projects that involve complex computational and experimental analyses of coding genes, transcript identification, and developing databases like APPRIS and FireDB. Their research spans human and mouse genomic data, with objectives including unifying reference gene databases, implementing new computational tools, and preparing for emerging genomic assemblies like the CHM13-T2T assembly and pangenome. These sub-awards demonstrate the organization's high-level scientific capabilities in molecular biology, cancer research, and bioinformatics.

Quick answers

Is Fundacion Centro Nacional De Investigaciones Oncologicas Carlos III registered in SAM.gov?

Fundacion Centro Nacional De Investigaciones Oncologicas Carlos III's SAM.gov registration expired on February 6, 2026.

What is Fundacion Centro Nacional De Investigaciones Oncologicas Carlos III's most recent federal award?

Fundacion Centro Nacional De Investigaciones Oncologicas Carlos III's most recent federal grant award is Clinical qualification of DNA repair defects as biomarkers in metastatic prostate cancer using integrated genomics… (W81XWH1810770), from Defense Health Agency, on September 30, 2018.

On GovTribe

See Fundacion Centro Nacional De Investigaciones Oncologicas Carlos III's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login